position, was deployed by slow balloon inflation under rapid ventricular pacing. Rapid ventricular pacing was performed using a permanent pacemaker via the epicardium (patient 1) or the coronary sinus (patients 2 and 3). In all patients, a 26-mm Sapien XT valve was successfully implanted. After the final results had been evaluated in the catheterization laboratory by echocardiography and fluoroscopy, patients underwent a computed tomographic scan before discharge using computed 3D reconstruction ( Figure 3 ).
On predischarge echocardiographic examination, mean transvalvular gradients ranged from 3 to 5 mm Hg and paravalvular TR around the Sapien valve was mild in patient 1, absent in patient 2, and moderate-to-severe in patient 3 (Figure 1A′ -C′; Movies I-IV in the Data Supplement). At 30-day follow-up, there was no complication and all patients had a significant improvement in their functional status (New York Heart Association classes I or II). At 1-year follow-up, they were alive with no change in their functional status. The tricuspid gradients remained stable.
Discussion
Although the feasibility of transcatheter valve-in-ring implantation in mitral position has been demonstrated, 1,2 only 2 case reports on the immediate results of TVIRI have been published, 3, 4 using the transatrial and the transfemoral approaches, and the latter concerned a patient presented in this series (patient 1).
One important difficulty is the proper evaluation of the prosthesis size, because Carpentier Edwards Classic tricuspid rings are oval, open, and surrounded by valvular tissue, which cannot be detected by computed tomographic scanner or fluoroscopy. In this series, 2 patients (1 and 3) had a residual paravalvular leak at the level of the open portion of the ring, probably because of the oval shape and the inability to completely seal the open segment with the transcatheter heart valve. Balloon sizing might have been performed and led to implantation of a 29-mm Sapien XT valve, with less degree Tricuspid Valve-in-Ring Implantation of paravalvular TR. However, the difficulty of changing the rings' geometry is illustrated by Figure 3 showing computed tomographic acquisitions before and after balloon-expandable valve implantation, along with the diameters (Figure 3) .
Thus, TVIRI with the current generation of Sapien XT valves should be considered with caution. In the presence of severe residual paravalvular TR, its immediate correction should be technically feasible and might be considered. In the future, more conformable or repositionable valves, with additional sealing capacity may help to reduce regurgitation after TVIRI.
The transfemoral approach has the advantage of being less invasive than a transatrial approach and the avoidance of a thoracotomy was desirable given the high-risk profile of our patients.
Rapid ventricular pacing had to take into account the potential damage to the lead of a permanent pacemaker across the ring and also avoid jailing a temporary pacing lead. In 2 patients who had permanent pacemaker, we chose to implant another lead in the coronary sinus. The third patient had a permanent epicardial pacemaker placed before the procedure because of sinus dysfunction.
This small series suggests that transfemoral TVIRI after failure of tricuspid surgery is feasible and may improve hemodynamic and functional status in highly selected patients, both immediately and at 1-year follow-up. Larger series with longer follow-up are needed to assess the potential role of this technique and will certainly be useful for future tricuspid transcatheter valve therapies with dedicated devices.
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